SHTDF News and Press, Sinopharm Group Co. Ltd.

2024-06-03 05:49:03 ET Summary Sinopharm Group faces near-term challenges like declining drug prices and lower sales from hospitals. But SHTDF's valuations could re-rate in the long term, if certain drivers such as industry consolidation, SOE reform, and sales mix optimization mat...

2023-11-24 12:35:42 ET More on BioNTech, GSK, etc. BioNTech Vs. Moderna: Navigating The mRNA Landscape Pfizer Is A Fantastic Buy And So Are These 9%-Yielding Blue Chips Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade) GSK makes ...

2023-05-18 14:13:29 ET Following a meeting of an advisory panel, the World Health Organization announced its recommendations supporting the use of reformulated COVID vaccines to reflect the currently dominant variants such as XBB.1 Noting that XBB.1 descendent lineages have outnumbered ...

2023-05-04 14:28:34 ET A panel of experts at the World Health Organization (WHO) is expected to meet on Thursday to discuss whether the current COVID-19 pandemic will remain a global emergency, the U.N. agency's highest alert level. The head of the WHO, Dr. Tedros Adhanom Ghebreyesus, i...

2023-04-17 01:35:00 ET Summary Pfizer announced a major partnership with Shanghai’s Sinopharm to market up to 12 innovative drugs in China over the next three years. Shanghai Junshi Biosciences said its PARP inhibitor met its primary efficacy endpoint as a maintenance thera...

2023-04-13 11:15:45 ET Pfizer ( NYSE: PFE ) announced Thursday a strategic corporation agreement with Shanghai-based Sinopharm Group ( OTCPK:SHTDF ) ( OTCPK:SHTDY ) to expand its market presence in China. Per the terms, the two companies will join hands to seek approva...

2023-04-06 14:14:11 ET After more than three years, the World Health Organization (WHO) could announce an end to the emergency status of COVID-19 this year, the head of the global body Dr. Tedros Adhanom Ghebreyesus, said Thursday. In early 2020, the WHO named the COVID-19 pandemic a Pu...

2023-04-04 08:48:47 ET The makers of oral COVID-19 treatments, Pfizer ( NYSE: PFE ) and Merck ( NYSE: MRK ), have reportedly reduced the prices of their respective medicines, Paxlovid and molnupiravir, in China, according to pricing information published by the province of...

2023-04-04 07:07:13 ET The makers of oral COVID-19 treatments, Pfizer ( NYSE: PFE ) and Merck ( NYSE: MRK ), have reportedly reduced the prices of their respective medicines, Paxlovid and molnupiravir, in China, according to pricing information published by the province of...

2023-03-28 12:05:00 ET The World Health Organization (WHO) issued revised recommendations for prioritizing the use of COVID-19 vaccines on Tuesday, including healthy children and adolescents in a low-priority group for immunizations. The announcement follows a meeting of the agency&...